Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 17, 2007
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals Inc
|
0
|
$17.94 | -$440,652.87 |
—
| 3.98K | +1 |
Apr 13
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Dec 18
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
$14.67 | -$1,547,180.00 |
—
| 3.57K | +1 |
Oct 31
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
| -3.46K |
$12.61 | -$178,487.78 | -49.20% | 3.57K | +1 |
Sep 1
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
| -5.68K |
$16.12 | -$91,592.16 | -47.52% | 6.28K | +1 |
Jan 5 - Jan 9
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Dec 19
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 5
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Dec 15
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
$5.76 | -$30,200.00 |
—
| 11.39K | +1 |
Oct 15
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
|
0
|
$5.79 | -$30,770.00 |
—
| 11.39K | +1 |
Oct 14
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
|
0
|
$6.10 | -$111,110.00 |
—
| 11.39K | +1 |
Oct 13
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
|
0
|
$6.36 | -$75,344.00 |
—
| 11.39K | +1 |
Jul 14
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
| 6.73K |
—
|
—
| +158.23% | 10.98K | +1 |
Dec 15
| ||||||
Regeneron Pharmaceuticals Inc
| -3.57K |
$20.40 | -$72,884.47 | -45.66% | 4.25K | +1 |
Sep 15
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||